Safety of a single dose of HC022 in healthy adults
Part of Immune system & allergy, Skin clinical trials.
This trial tests a single dose of an investigational drug called HC022 in healthy volunteers to see how safe it is and how the body handles it. If you are a healthy adult, you may be able to join and help researchers learn the first steps about this new medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You weigh at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female, and your BMI is between 19 and 28.
- You are generally healthy, with no serious medical conditions or infections.
- You have not participated in another trial in the last 3 months.
- You are willing to use effective birth control during the study and for several months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new experimental drug called ACT100 in healthy people to see if it is safe and how it works in the body. It is an early study, so it is not testing whether the drug helps treat a disease yet.
This trial tests an experimental medicine called HN2302 in people with certain autoimmune diseases like lupus or scleroderma. The goal is to see if it is safe and if it can help reduce disease activity, which might improve symptoms.
This study tests a new drug called LBL-047 in healthy people and in people with mild to moderate lupus. It helps check if the drug is safe and how the body processes it. Participating may help find better treatments for lupus.
This early-phase study tests a new medicine called HC022 for people with lupus (SLE) or lupus skin disease (CLE). The goal is to check its safety and see if it helps reduce symptoms, and the study will monitor you closely.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.